Title 201 | Chapter 027 | Regulation 023REG
PROPOSED
This document is not yet current.
PREVIOUS VERSION
The previous document that this document is based upon is available.
PUBLIC PROTECTION CABINET
Boxing and Wrestling Commission
(Amended at ARRS Committee)
201 KAR 27:023.Drug testing for unarmed combatboxing, kickboxing, mixed martial arts, and wrestling, and elimination event shows.
Section 1.
Definitions.(1)
"In-competition" means the period commencing twelve (12) hours before the beginning of a bout, match, or exhibition of unarmed combat in which the licensee is scheduled to participate through the end of the bout, match, or exhibition and the sample collection process related to the bout match or exhibition.(2)
"Out-of-competition" means any period that is not in-competition.(3)
"Prohibited List" means the World Anti-Doping Agency Prohibited ListSection 2.
Applicability. This administrative regulation shall apply to all contestants, judges, and referees in unarmed combatSection 3.
Prohibitions.(1)
The Prohibited List shall be used in conjunction with this administrative regulation.(2)
Except as established in Section 4 of this administrative regulation, the substances and methods listed in the following classes of the World Anti-Doping Agency Prohibited List shall be prohibited in-competition and out-of-competition:(a)
S0. Non-approved substances;(b)
S1. Anabolic agents;(c)
S2. Peptide hormones, growth factors, and related substances and mimetics;(d)
S3. Beta-2 agonists;(e)
S4. Hormone and metabolic modulators;(f)
S5. Diuretics and masking agents;(g)
M1. Manipulation of blood and blood components;(h)
M2. Chemical and physical manipulation; and(i)
M3. Gene Doping.(3)
Except as established in Section 4 of this administrative regulation, the following substances listed in the World Anti-Doping Agency Prohibited List shall be prohibited only if(a)
S6. Stimulants;(b)
S7. Narcotics;(c)
S8. Cannabinoids; and(d)
S9. Glucocorticoids(e)
Section 4.
Approved Substances. The following types of drugs or injections are approved:(1)
Antacids, such as Maalox;(2)
Antibiotics, antifungals, or antivirals for which the licensee has a prescription;(3)
Antidiarrheals, such as Imodium, Kaopectate, or Pepto-Bismol;(4)
Antihistamines for colds or allergies, such as Bromphen, Brompheniramine, Chlorpheniramine Maleate, Chlor-Trimeton, Dimetane, Hismal, PBZ, Seldane, Tavist-1, or Teldrin;(5)
Antinauseants, such as Dramamine or Tigan;(6)
Antipyretics, such as Tylenol;(7)
Antitussives, such as Robitussin, if the antitussive does not contain codeine;(8)
Antiulcer products, such as Carafate, Pepcid, Reglan, Tagamet, or Zantac;(9)
Asthma products in aerosol form, such as Brethine, Metaproterenol (Alupent), or Salbutamol (Albuterol, Proventil, or Ventolin);(10)
Asthma products in oral form, such as Aminophylline, Cromolyn, Nasalide, or Vanceril;(11)
Ear products, such as Auralgan, Cerumenex, Cortisporin, Debrox, or Vosol;(12)
Hemorrhoid products, such as Anusol-HC, Preparation H, or Nupercainal;(13)
Laxatives, such as Correctol, Doxidan, Dulcolax, Efferyllium, Ex-Lax, Metamucil, Modane, or Milk of Magnesia;(14)
Nasal products, such as AYR Saline, HuMist Saline, Ocean, or Salinex; and(15)
The following decongestants and any decongestant that is pharmaceutically similar:(a)
Afrin; or(b)
Oxymetazoline HCL Nasal Spray.Section 5.
Testing Requirement.Section 6.
Violations and Penalties.(1)
A licensee who violates any provision of this administrative regulation shall be subject to a penalty issued by the commission.(2)
A blood test shall not be required within seven (7) days of the bout, competition, or exhibition unless directed by the commission upon finding of probable cause that a violation of Section 3 of this administrative regulation has occurred.(3)
(a)
In addition to any other penalty issued by the commission pursuant to KRS 229.200 and 201 KAR 27:106, if a contestant who won or drew a bout is found to have violated the provisions of this administrative regulation, the commission may change the result of that bout to a no decision loss if the commission finds that the drug used may have affected the result.(b)
A note shall be placed on the contestant's record that the change in decision was the result of testing positive for a banned substance or prohibited method.(4)
The commission shall investigate each alleged violation of this administrative regulation.Section 7.
Penalty Guidelines. The guidelines for use in determining a penalty pursuant to 201 KAR 27:106(1)
For cannabis or cannabinoids:(a)
1st offense: six (6) month suspension and a fine of fifty (50) dollars;(b)
2nd offense: twelve (12) month suspension and a $100 fine;(c)
3rd offense: twenty-four (24) month suspension and a $250 fine; or(d)
4th offense: lifetime ban and a $500 fine;(2)
For sedatives, muscle relaxants, sleep aids, anxiolytics, opiates, or opioids:(a)
1st offense: eighteen (18) month suspension and a $100 fine;(b)
2nd offense: twenty-four (24) month suspension and a $250 fine;(c)
3rd offense: thirty-six (36) month suspension and a $500 fine; or(d)
4th offense: lifetime ban and a $1,000 fine;(3)
For diuretics being used to cut weight:(a)
1st offense: twenty-four (24) month suspension and a $250 fine;(b)
2nd offense: thirty-six (36) month suspension and a $500 fine; or(c)
3rd offense: lifetime ban and a $1,000 fine;(4)
For stimulants:(a)
1st offense: twenty-four (24) month suspension and a $250 fine;(b)
2nd offense: thirty-six (36) month suspension and a $500 fine; or(c)
3rd offense: lifetime ban and a $1,000 fine;(5)
For anabolic steroids:(a)
1st offense: thirty-six (36) month suspension and a $500 fine;(b)
2nd offense: forty-eight (48) month suspension and a $750 fine; or(c)
3rd offense: lifetime ban and a $1,000 fine; or(6)
For avoiding or refusing testing or detection, altering or adulterating a urine or blood sample, providing a urine or blood sample not from the contestant, or using any masking agent:(a)
1st offense: forty-eight (48) month suspension and a $750 fine; or(b)
2nd offense: lifetime ban and a $1,000 fine.Section 8.
Incorporation by Reference.(1)
"World Anti-Doping Agency Prohibited List", January 2024, is incorporated by reference.(2)
This material may be inspected, copied, or obtained, subject to applicable copyright law, at the Kentucky Boxing and Wrestling Commission office at 500 Mero St, 218NC, Frankfort, Kentucky 40601, Monday through Friday, 8 a.m. to 4:30 p.m., and is available online at https://www.wada-ama.org/en/resources/world-anti-doping-code-and-international-standards/prohibited-list.FILED WITH LRC: September 10, 2024
CONTACT PERSON: Doug Hardin, Staff Attorney, 500 Mero Street 254 CW, Frankfort, Kentucky 40601, phone (502) 782-8204, and email doug.hardin@ky.gov.
PUBLIC PROTECTION CABINET
Boxing and Wrestling Commission
(Amended at ARRS Committee)
201 KAR 27:023.Drug testing for unarmed combat shows.
Section 1.
Definitions.(1)
"In-competition" means the period commencing twelve (12) hours before the beginning of a bout, match, or exhibition of unarmed combat in which the licensee is scheduled to participate through the end of the bout, match, or exhibition and the sample collection process related to the bout match or exhibition.(2)
"Out-of-competition" means any period that is not in-competition.(3)
"Prohibited List" means the World Anti-Doping Agency Prohibited List.Section 2.
Applicability. This administrative regulation shall apply to all contestants, judges, and referees in unarmed combat.Section 3.
Prohibitions.(1)
The Prohibited List shall be used in conjunction with this administrative regulation.(2)
Except as established in Section 4 of this administrative regulation, the substances and methods listed in the following classes of the World Anti-Doping Agency Prohibited List shall be prohibited in-competition and out-of-competition:(a)
S0. Non-approved substances;(b)
S1. Anabolic agents;(c)
S2. Peptide hormones, growth factors, and related substances and mimetics;(d)
S3. Beta-2 agonists;(e)
S4. Hormone and metabolic modulators;(f)
S5. Diuretics and masking agents;(g)
M1. Manipulation of blood and blood components;(h)
M2. Chemical and physical manipulation; and(i)
M3. Gene Doping.(3)
Except as established in Section 4 of this administrative regulation, the following substances listed in the World Anti-Doping Agency Prohibited List shall be prohibited only if a licensee is in-competition:(a)
S6. Stimulants;(b)
S7. Narcotics;(c)
S8. Cannabinoids; and(d)
S9. Glucocorticoids.Section 4.
Approved Substances. The following types of drugs or injections are approved:(1)
Antacids, such as Maalox;(2)
Antibiotics, antifungals, or antivirals for which the licensee has a prescription;(3)
Antidiarrheals, such as Imodium, Kaopectate, or Pepto-Bismol;(4)
Antihistamines for colds or allergies, such as Bromphen, Brompheniramine, Chlorpheniramine Maleate, Chlor-Trimeton, Dimetane, Hismal, PBZ, Seldane, Tavist-1, or Teldrin;(5)
Antinauseants, such as Dramamine or Tigan;(6)
Antipyretics, such as Tylenol;(7)
Antitussives, such as Robitussin, if the antitussive does not contain codeine;(8)
Antiulcer products, such as Carafate, Pepcid, Reglan, Tagamet, or Zantac;(9)
Asthma products in aerosol form, such as Brethine, Metaproterenol (Alupent), or Salbutamol (Albuterol, Proventil, or Ventolin);(10)
Asthma products in oral form, such as Aminophylline, Cromolyn, Nasalide, or Vanceril;(11)
Ear products, such as Auralgan, Cerumenex, Cortisporin, Debrox, or Vosol;(12)
Hemorrhoid products, such as Anusol-HC, Preparation H, or Nupercainal;(13)
Laxatives, such as Correctol, Doxidan, Dulcolax, Efferyllium, Ex-Lax, Metamucil, Modane, or Milk of Magnesia;(14)
Nasal products, such as AYR Saline, HuMist Saline, Ocean, or Salinex; and(15)
The following decongestants and any decongestant that is pharmaceutically similar:(a)
Afrin; or(b)
Oxymetazoline HCL Nasal Spray.Section 5.
Testing Requirement. A licensed unarmed combat contestant, judge, or referee shall submit to a blood test, urinalysis, or chemical test at any time, in-competition or out-of-competition, if the commission or a representative of the commission directs him or her to do so.Section 6.
Violations and Penalties.(1)
A licensee who violates any provision of this administrative regulation shall be subject to a penalty issued by the commission.(2)
A blood test shall not be required within seven (7) days of the bout, competition, or exhibition unless directed by the commission upon finding of probable cause that a violation of Section 3 of this administrative regulation has occurred.(3)
(a)
In addition to any other penalty issued by the commission pursuant to KRS 229.200 and 201 KAR 27:106, if a contestant who won or drew a bout is found to have violated the provisions of this administrative regulation, the commission may change the result of that bout to a no decision loss if the commission finds that the drug used may have affected the result.(b)
A note shall be placed on the contestant's record that the change in decision was the result of testing positive for a banned substance or prohibited method.(4)
The commission shall investigate each alleged violation of this administrative regulation.Section 7.
Penalty Guidelines. The guidelines for use in determining a penalty pursuant to 201 KAR 27:106, Section 3 shall be as follows:(1)
For cannabis or cannabinoids:(a)
1st offense: six (6) month suspension and a fine of fifty (50) dollars;(b)
2nd offense: twelve (12) month suspension and a $100 fine;(c)
3rd offense: twenty-four (24) month suspension and a $250 fine; or(d)
4th offense: lifetime ban and a $500 fine;(2)
For sedatives, muscle relaxants, sleep aids, anxiolytics, opiates, or opioids:(a)
1st offense: eighteen (18) month suspension and a $100 fine;(b)
2nd offense: twenty-four (24) month suspension and a $250 fine;(c)
3rd offense: thirty-six (36) month suspension and a $500 fine; or(d)
4th offense: lifetime ban and a $1,000 fine;(3)
For diuretics being used to cut weight:(a)
1st offense: twenty-four (24) month suspension and a $250 fine;(b)
2nd offense: thirty-six (36) month suspension and a $500 fine; or(c)
3rd offense: lifetime ban and a $1,000 fine;(4)
For stimulants:(a)
1st offense: twenty-four (24) month suspension and a $250 fine;(b)
2nd offense: thirty-six (36) month suspension and a $500 fine; or(c)
3rd offense: lifetime ban and a $1,000 fine;(5)
For anabolic steroids:(a)
1st offense: thirty-six (36) month suspension and a $500 fine;(b)
2nd offense: forty-eight (48) month suspension and a $750 fine; or(c)
3rd offense: lifetime ban and a $1,000 fine; or(6)
For avoiding or refusing testing or detection, altering or adulterating a urine or blood sample, providing a urine or blood sample not from the contestant, or using any masking agent:(a)
1st offense: forty-eight (48) month suspension and a $750 fine; or(b)
2nd offense: lifetime ban and a $1,000 fine.Section 8.
Incorporation by Reference.(1)
"World Anti-Doping Agency Prohibited List", January 2024, is incorporated by reference.(2)
This material may be inspected, copied, or obtained, subject to applicable copyright law, at the Kentucky Boxing and Wrestling Commission office at 500 Mero St, 218NC, Frankfort, Kentucky 40601, Monday through Friday, 8 a.m. to 4:30 p.m., and is available online at https://www.wada-ama.org/en/resources/world-anti-doping-code-and-international-standards/prohibited-list.FILED WITH LRC: September 10, 2024
CONTACT PERSON: Doug Hardin, Staff Attorney, 500 Mero Street 254 CW, Frankfort, Kentucky 40601, phone (502) 782-8204, and email doug.hardin@ky.gov.